Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
SyringomyeliaChiari Malformation
Interventions
OTHER

focus groups

A dozen patients with Chiari malformation and syringomyelia (n = 4) or isolated Chiari malformation (n = 4) or isolated syringomyelia (n = 4) will be brought together in at least two focus groups. Each focus group will include 5 to 8 patients and will last approximately 1 to 2 hours. The focus groups will be recorded (audio only, no personal data will be collected during these sessions) and will be conducted in the presence of a neurosurgeon and a psychologist, who will moderate the session.

OTHER

questionnaire

developed questionnaire will be proposed to the patients in phase 2 and 3

Trial Locations (1)

94270

Hôpital Bicêtre - Service de Neurochirurgie - CRMR C-MAVEM, Le Kremlin-Bicêtre

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06011226 - Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia | Biotech Hunter | Biotech Hunter